Health Care/Hospital
Novozymes opens online store on Alibaba
HANGZHOU, China, May 21, 2019 /PRNewswire/ -- China is a pioneer when it comes to e-commerce, and Alibaba is the country's biggest platform, offering everything from clothes, furniture, electronics to food, cars and home products. Now, for the first time, Novozymes' enzymes are available online ...
Inovio First to Advance Lassa Fever Candidate Vaccine Into a Clinical Trial
Subjects dosed in First-in-Human study of INO-4500 funded by the Coalition for Epidemic Preparedness Innovations Planned for emergency use as a stockpiled vaccine PLYMOUTH MEETING, Pa. and OSLO, Norway, May 21, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO), together with CEPI, ...
Nektium Pharma Commended by Frost & Sullivan for Introducing Zynamite®, a Novel Natural Extract with Ergogenic and Nootropic Properties
The product is a caffeine alternative and offers a range of benefits like superior mental and physical performance LONDON, May 21, 2019 /PRNewswire/ -- Based on its recent analysis of the European sports nutrition and health ingredients market, Frost & Sullivan recognisesSpain-based Nektium Phar...
AXA Hong Kong expands Medical Service in Greater Bay Area
HONG KONG, May 21, 2019 /PRNewswire/ -- AXA Hong Kong and University of Hong Kong-Shenzhen Hospital ("HKU-SZH") held their contract signing ceremony today, announcing HKU-SZH as the first official medical partner of "AXA Signature Network" ("the Network") in the Greater Bay Area. AXA Hong Kong's ...
First Sublingual Ketamine Drug for Treatment of Acute Pain to be Evaluated in End-of-Phase 2 Meeting with FDA
* Racemic sublingual ketamine, Wafermine, is the first sublingual ketamine drug seeking FDA approval for the treatment of moderate to severe acute pain * Wafermine is a Phase 2-ready drug for treatment resistant depression SINGAPORE, May 21, 2019 /PRNewswire/ -- iX Biopharma Ltd (SGX:42C) anno...
WuXi Biologics Signed Letter of Intent for Long-Term Vaccine Manufacturing Contract
SHANGHAI, May 21, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, today announced that it has entered into a strategic partnership L...
Week's Top Stories
Most Reposted
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
[Picked up by 327 media titles]
2024-05-17 07:00Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 321 media titles]
2024-05-15 12:00Innomix and World Castle Association Pioneer LBMR project at Zhangbi Fortress
[Picked up by 310 media titles]
2024-05-20 13:48Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 308 media titles]
2024-05-16 15:00US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 278 media titles]
2024-05-16 09:39